Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.8K
Inflammation01:38

Inflammation

63.8K
Overview
63.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

879
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
879
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

700
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
700
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

564
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy.

European heart journal·2026
Same author

NLRP3 Inflammasome Inhibition by the Novel Bispecific Antibody InflamAb Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.

JACC. Basic to translational science·2025
Same author

Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr<sup>-/-</sup> mice.

European journal of pharmacology·2024
Same author

Integrated metabolic-transcriptomic network identifies immunometabolic modulations in human macrophages.

Cell reports·2024
Same author

DHCR24 inhibitor SH42 increases desmosterol without preventing atherosclerosis development in mice.

iScience·2024
Same author

Sexual dimorphism in atherosclerotic plaques of aged Ldlr<sup>-/-</sup> mice.

Immunity & ageing : I & A·2024

Related Experiment Video

Updated: Mar 17, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

3.2K

Novel B-cell subsets in atherosclerosis.

Hidde Douna1, Johan Kuiper

  • 1Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Current Opinion in Lipidology
|July 30, 2016
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease remains a leading cause of death. Recent research reveals B-cell subsets, not just antibodies, significantly impact atherosclerosis, necessitating a nuanced understanding of their roles.

More Related Videos

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

35.4K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Related Experiment Videos

Last Updated: Mar 17, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

3.2K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

35.4K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Atherosclerosis Pathogenesis

Background:

  • Cardiovascular disease (CVD) mortality remains high despite advances in cholesterol management.
  • Atherosclerosis, the primary pathology of CVD, is an inflammatory disease with complex immune involvement.
  • The role of B cells in atherosclerosis has traditionally been viewed as protective, but this is being re-evaluated.

Purpose of the Study:

  • To review the current understanding of B-cell subset functions in atherosclerosis.
  • To explore the potential impact of newly identified B-cell subsets on this disease.
  • To highlight the need for differentiating B-cell subsets in atherosclerosis research.

Main Methods:

  • Literature review of recent immunological and cardiovascular research.
  • Analysis of studies investigating B-cell subsets and their mediators (cytokines, surface markers).
  • Synthesis of findings on B-cell independent immune effects in autoimmune and inflammatory conditions.

Main Results:

  • B cells exert significant immune effects beyond antibody production.
  • Novel B-cell subsets influence T-cell responses and cytokine profiles.
  • These subsets are implicated in autoimmune disorders and warrant further investigation in atherosclerosis.

Conclusions:

  • The role of B cells in atherosclerosis is complex and subset-dependent.
  • Understanding non-antibody mediated functions of B-cell subsets is crucial for novel therapeutic strategies.
  • Further research into recently identified B-cell subsets is needed to elucidate their specific contributions to atherosclerosis.